France – Intérêt du logiciel doté d’IA « PharmaClass » pour aider le pharmacien clinicien à...
LILLE (TICsanté) - Le logiciel "PharmaClass", qui utilise l'intelligence artificielle (IA), aide le pharmacien clinicien à sécuriser la prise en charge médicamenteuse à l'hôpital,...
International – Pherecydes Pharma : autorisation d’un 1er traitement compassionnel avec ses phages à...
Pherecydes Pharma, société de biotechnologie spécialisée dans la phagothérapie de précision destinée à traiter les infections bactériennes résistantes et/ou compliquées, a annoncé avoir reçu...
International – ORGANOIDES : Néovacs investit dans NETRI et enrichit son portefeuille de participations...
Néovacs a annoncé un investissement dans la société NETRI, start-up industrielle lyonnaise qui développe des technologies innovantes d’organes sur puce pour l’industrie pharmaceutique, les...
International – Omicron hospitalization risk higher among unvaccinated
Unvaccinated adults were 23 times more likely to be hospitalized with the COVID-19 Omicron variant than those who were fully vaccinated and had received...
USA – 10-year study shows CAR T-cell therapy cured cancer in 2 patients
In 2010, doctors treated Doug Olson’s leukemia with an experimental gene therapy that transformed some of his blood cells into cancer killers. More than...
USA – Dosing begins in mRNA HIV vaccine trial
The first participants have been vaccinated in a Phase 1 clinical trial of an experimental HIV vaccine that utilizes Moderna's mRNA technology, the company announced last...
Switzerland – COVID-19 patch vaccine trial launched
Swiss medical researchers said on Wednesday (Jan 19) they have launched an early-stage study to test a next-generation COVID-19 vaccine candidate which would be...
UK – Study finds Omicron multiplies 70 times faster than Delta, UK COVID-19 cases...
A study run by researchers in Hong Kong has found that the Omicron variant of COVID-19 multiplies 70 times faster than Delta in human...
USA – Viagra associated with reduced risk of Alzheimer’s disease
Alzheimer’s disease (AD) is the most common form of dementia. It is expected to affect 16 million Americans by 2050. The hallmarks of AD...
International – Challenges of non-clinical safety testing for biologics: A Report of the 9th...
New challenges and other topics in non-clinical safety testing of biotherapeutics were presented and discussed at the nineth European BioSafe Annual General Membership meeting...
